Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD)…
Press
KCBS Radio afternoon anchor and A2A founder Jeff Bell spotlights Victoria Jackson and the work she and her family are doing to find a cure for…
October 23, 2018 | Beverly Hills, CA — Chugai Pharmaceutical Co. announced positive results from one of its phase III clinical trials of satralizumab (SA237),…
Featured Videos
